Twi Pharmaceuticalsincis A Specialty Pharmaceutical Company Focused On Developing And Commercializing Niche Generic Drugsfounded In 2010 And Headquartered In Taiwantwi Has A Significant Presence In The United Statesparticularly In Paramusnew Jerseythe Company Aims To Establish Itself As A Leading Provider Of High Qualityaffordable Generic And New Drugs In The Us Market Twi Specializes In Niche Generic Drugs That Require Advanced Scientific Research And Technical Expertisethis Includes High Technical Barrier Generic Drugssuch As Paragraph Iv Genericsand Under Serviced Mature Moleculesrecent Product Launches Include Guanfacine Hcl Tabletstestosterone Topical Solution Ciiidiltiazem Hcl Sr Capsulesand Dicyclomine Hydrochloride Capsulestwi S Strategic Goals Include Competing Globally And Achieving Sustainable Profits Through Its Innovative Drug Pipeline
